摘要
地诺孕素(dienogest)作为一种新型的高效孕激素,也是第一个针对子宫内膜异位症的药物,在中国以外的市场已经应用了11年,积累了相应的疗效与安全性等方面的经验。本文将围绕地诺孕素在不同类型子宫内膜异位症治疗中的应用进行综述,并介绍其在亚洲人群的患者中的临床试验开展情况,有助于临床医生更全面了解地诺孕素在子宫内膜异位症治疗中的应用价值。
As a new high-potency progesterone and the first drug for endometriosis,dienogest has been used in overseas markets for 11 years,accumulating relevant experience in efficacy and safety.This article reviewed the application of dienogest in the treatment of different types of endometriosis,and the results of clinical trials in Asian patients.It would help the clinicians fully understand the application value of dienogest in the treatment of endometriosis.
作者
郑韵熹
易晓芳
徐丛剑
Zheng Yunxi;Yi Xiaofang;Xu Congjian(Obstetrics and Gynecology Hospital,Fudan University,Shanghai 200011,China)
出处
《中华生殖与避孕杂志》
CAS
CSCD
北大核心
2020年第10期828-831,共4页
Chinese Journal of Reproduction and Contraception